- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02784041
Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty
April 4, 2017 updated by: Peking Union Medical College Hospital
Comparison of the Effect of Single Adductor-canal-block and Peri-articular Infiltration on the Outcome After Unilateral Total Knee Arthroplasty
The purpose of this study is to compare the effect of single adductor-canal-block versus single femoral nerve block on the recovery after total knee arthroplasty.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to assess the effect of different analgesic effects on the outcome of patients undergoing total knee arthroplasty.
Patients who will have primary unilateral total knee replacement between September 2016 to June 2018 at Peking Union Medical College Hospital and meet the inclusion criteria will be included.
They are randomized into two groups.
The total knee arthroplasty is performed by one surgeon and adductor-canal block is performed by one anesthesiologist who is not responsible for follow-up.
Patients on both groups will have intravenous patient control analgesia with 1 mg morphine/bolus.
One residency is responsible for the follow-up.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100730
- Peking Union Medical College Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- osteoarthritis
- unilateral total knee arthroplasty
- ASA grade I - II
- normal cognitive function.
Exclusion Criteria:
- patients refuse
- BMI > 35
- diagnosis other than osteoarthritis
- allergy to the drugs used or contraindication to the intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: single adductor-canal-block
Patients in this group will receive ultrasound guided single adductor-canal- block with 0.35% ropivacaine 25ml.
|
Single adductor-canal-block is performed before the surgery.
A 12Hz linear ultrasound transducer is placed on the medial part of the thigh with the leg slightly externally rotated.
The femoral artery was identified in short axis in the adductor canal, underneath the sartorius muscle.
After skin disinfection , an 18-gauge needle (B.Braun Medical, Melsungen, Germany) is inserted in-plane from the lateral side of the transducer.
The needle tip was placed underneath the sartorius muscle, just lateral to the artery and saphenous nerve, using 2-3 ml of saline to ensure correct placement.
25 ml of 0.35% ropivacaine is slowly injected with repeated aspiration.
|
|
EXPERIMENTAL: periarticular infiltration
patients in this group will receive periarticular infiltration of local anesthetic.
|
The periarticular infiltration of multimodal agents will involve the preparation of a mixture of 100 ml solution.
The mixture contains 30ml (300mg) ropivacaine, 0.5ml (5 mg) morphine, 2 ml (50 mg) flurbiprofen and 0.5 ml of 1:1000 epinephrine, and then is diluted with 0.9% normal saline to a total volume of 100ml.
50 ml of mixture will be injected into the anterior, medial and lateral soft tissues after the implantation of the joint prostheses.
The remaining 50 ml of mixture will be injected into intraarticular space after the closure of articular capsule.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the time required for functional recovery
Time Frame: from the date of the surgery to the time when the patients meet the criteria of functional recovery. The earliest day on which the patient achieves the criteria of functional recovery will be recorded and the average time is 7 days after surgery.
|
Patients are evaluated postoperatively to determine whether the patients have meet the criteria of functional recovery.The criteria of functional recovery are as followings: walking distance more than 70m with crutch, getting up or standing up independently and visual analog score less than 5 both in rest and after movement.
Before discharge, patients are assessed every morning.
After discharge, patients are followed up by phone every two days.
|
from the date of the surgery to the time when the patients meet the criteria of functional recovery. The earliest day on which the patient achieves the criteria of functional recovery will be recorded and the average time is 7 days after surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative WOMAC scales
Time Frame: pre-operative, three months,six months and one year afer the surgery
|
We compare the WOMAC scales of two groups before, three months, six months, and one year after the surgery.
|
pre-operative, three months,six months and one year afer the surgery
|
|
Postoperative complications
Time Frame: daily after the surgery until discharge from hospital, expected average up to 5 days after the surgery
|
Any complication, including nause and vomiting, deep vein thrombosis, pulmonary embolism, pulmonary infection, urinary tract infection,cardiovascular event and falls are recorded during inhospital stay.
|
daily after the surgery until discharge from hospital, expected average up to 5 days after the surgery
|
|
postoperative VAS scale
Time Frame: pre-operative, 6h postoperative, 24h postoperative, 48h postoperative, one month postoperative, three-month postoperative, one year postoperative
|
Pain at rest and while moving are evaluated by a visual analog scale preoperative, 6h, 24h, 48h, 1month, 3 months and 1 year after the surgery.
|
pre-operative, 6h postoperative, 24h postoperative, 48h postoperative, one month postoperative, three-month postoperative, one year postoperative
|
|
postoperative morphine consumption
Time Frame: 6h, 24h, 48h after the surgery
|
Consumptions of morphine are recorded at 6h, 24h, 48h after the surgery.
|
6h, 24h, 48h after the surgery
|
|
postoperative SF-36 score
Time Frame: pre-operative, three months,six months and one year afer the surgery
|
We compare the SF-36 score of two groups before, three months,six months and one year after the surgery.
|
pre-operative, three months,six months and one year afer the surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patients' satisfaction
Time Frame: before discharge, usually 3-4 days after the surgery and one year after the surgery
|
The degree of satisfaction with surgery outcomes is assessed on a scale from fully satisfied to dissatisfied .
|
before discharge, usually 3-4 days after the surgery and one year after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Yuguang Huang, Dr, Peking Union Medical College Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (ANTICIPATED)
December 1, 2017
Study Completion (ANTICIPATED)
December 1, 2018
Study Registration Dates
First Submitted
May 15, 2016
First Submitted That Met QC Criteria
May 23, 2016
First Posted (ESTIMATE)
May 26, 2016
Study Record Updates
Last Update Posted (ACTUAL)
April 6, 2017
Last Update Submitted That Met QC Criteria
April 4, 2017
Last Verified
April 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZS-980
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis,Knee
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
Emory UniversityVertex Pharmaceuticals IncorporatedNot yet recruitingKnee Osteoarthritis | Knee ArthritisUnited States
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on single adductor-canal-block
-
Seoul National University HospitalSeoul National UniversityCompletedPostoperative PainKorea, Republic of
-
General Hospital of Ningxia Medical UniversityNot yet recruitingMuscle Strength | TKAChina
-
Kafrelsheikh UniversityNot yet recruitingPostoperative Analgesia | Morphine and Dexmedetomidine
-
Benaroya Research InstituteCompletedPost-Operative PainUnited States
-
Konya Beyhekim Training and Research HospitalNot yet recruitingTotal Knee Arthroplasty | Adductor Canal Block | IPACK Block Multimodal Analgesia | Genicular Nerves Block
-
Yonsei UniversityNot yet recruitingPostoperative Pain | Knee Osteoarthritis | Total Knee Arthroplasty | Peripheral Nerve Block | Adductor Canal Block
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedPostoperative Pain ManagementTurkey (Türkiye)
-
Karaman Training and Research HospitalCompletedOsteo Arthritis KneeTurkey
-
Fayoum University HospitalNot yet recruiting
-
Ain Shams UniversityNot yet recruitingFunctional Recovery | Adductor Canal Block | Total Knee Replacement Surgery